Matri Pharmaceuticals India Private Limited
About Matri Pharmaceuticals India Private Limited
Data last updated:
Matri Pharmaceuticals India Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 June 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U45400WB2014PTC202037. Its GSTIN is 19AAUCS6718C1ZW (West Bengal).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It was formerly known as Shiuli Infracon India Private Limited. It is led by directors Khuku Rani Sahoo and Kartic Chandra Sahoo.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 48/A Bhubanmohan Banerjee Road Belghoria Kamarhati, Kolkata, West Bengal, India – 700056.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.94 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹10,210 (net margin 0.6%) and EBITDA of ₹58,806 (EBITDA margin 3.3%). Revenue has declined at a compounded annual rate (CAGR) of 27% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Matri Pharmaceuticals India Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address48/A Bhubanmohan Banerjee Road Belghoria Kamarhati, Kolkata, West Bengal, India – 700056
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Matri Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Matri Pharmaceuticals India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Matri Pharmaceuticals India Private Limited, buy the company report.
Financials of Matri Pharmaceuticals India Private Limited
FY 2025 filings availableMatri Pharmaceuticals India Private Limited reported revenue of ₹17.94 Lakh (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 14% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA fell 89% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹58,806 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10,210 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Matri Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Matri Pharmaceuticals India Private Limited
Matri Pharmaceuticals India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Khuku Rani Sahoo | Director | 01 Dec 2018 | 7 Years 11 Months | Current |
| Kartic Chandra Sahoo | Director | 05 Jun 2014 | 12 Years 5 Months | Current |
Peer comparison
Matri Pharmaceuticals India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tradino Bio Technologies Private Limited | ₹17.99 Lakh (FY 2024) | 19.0% | Chennai, Tamil Nadu, India | |||
| Cardinem Wholesale Private Limited | ₹17.95 Lakh (FY 2024) | 266.0% | Kolkata, West Bengal, India | |||
| Matri Pharmaceuticals India Private Limitedthis company | ₹17.94 Lakh (FY 2025) | ₹10,210 | 0.6% | 14.0% | Kolkata, West Bengal, India | |
| Novox Pharmaceuticals Private Limited | ₹17.91 Lakh (FY 2022) | -41.0% | Lucknow, Uttar Pradesh, India | |||
| Shinemed Pharmaceuticals Private Limited | ₹17.87 Lakh (FY 2024) | -27.0% | Delhi, India |
To see the full peer comparison of Matri Pharmaceuticals India Private Limited, buy the company report.
Auditor
Matri Pharmaceuticals India Private Limited is audited by D MAJUMDER & COMPANY for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D MAJUMDER & COMPANY | FY 2019 | 327243E |
Shareholding
The shareholding of Matri Pharmaceuticals India Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Matri Pharmaceuticals India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Matri Pharmaceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Matri Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Matri Pharmaceuticals India has 2 associated companies. This group structure data is as of FY 2019. The table lists each entity with its relationship and holding.
GST
Matri Pharmaceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAUCS6718C1ZW | West Bengal | Active | 28 Jan 2018 |
To see the full GST registrations and return filing status of Matri Pharmaceuticals India Private Limited, buy the company report.
Recent activity
Matri Pharmaceuticals India Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Khuku Rani Sahoo was appointed as Director on 01 Dec 2018.
Frequently asked questions
Matri Pharmaceuticals India is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 June 2014 (12+ years old) and is registered under CIN U45400WB2014PTC202037.
Matri Pharmaceuticals India has 2 current directors:
- Khuku Rani Sahoo - Director
- Kartic Chandra Sahoo - Director
The latest financial statements of Matri Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Matri Pharmaceuticals India is 19AAUCS6718C1ZW, registered in West Bengal.
The CIN (Corporate Identification Number) of Matri Pharmaceuticals India is U45400WB2014PTC202037. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Matri Pharmaceuticals India was incorporated on 05 June 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Matri Pharmaceuticals India by revenue are Tradino Bio Technologies Private Limited, Cardinem Wholesale Private Limited, Novox Pharmaceuticals Private Limited, Shinemed Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Khuku Rani Sahoo was appointed as Director on 01 Dec 2018. Shiuli Rani Nayak Sahoo ceased to be Director on 01 Dec 2018. Kartic Chandra Sahoo was appointed as Director on 05 Jun 2014.
The registered office of Matri Pharmaceuticals India is at 48A Bhubanmohan Banerjee Road Belghoria Kamarhati, Kolkata, West Bengal, India – 700056.
Matri Pharmaceuticals India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Matri Pharmaceuticals India is compliant as of 26 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
